6.
Multivariate analysis of baseline factors associated with selection of docetaxel/other regimen selection
| Factor | Odds ratio | 95% CI | P |
| 95% CI, 95% confidence interval. | |||
| Age group (year) | |||
| 40–<65vs. <40 | 1.199 | (0.902, 1.594) | 0.212 |
| ≥65 vs. <40 | 2.716 | (1.759, 4.192) | <0.001 |
| Menopausal status | |||
| Peri-menopause vs. pre-menopause | 1.623 | (0.761, 3.461) | 0.210 |
| Post-menopause vs. pre-menopause | 1.316 | (1.079, 1.605) | 0.007 |
| Concomitant cardiovascular disease (yes vs. no) | 1.293 | (0.877, 1.905) | 0.194 |
| Progesterone receptor | |||
| Positive vs. negative | 1.370 | (1.145, 1.640) | <0.001 |
| Unknown vs. negative | 0.328 | (0.129, 0.833) | 0.019 |